[go: up one dir, main page]

DE1078581B - Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden - Google Patents

Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden

Info

Publication number
DE1078581B
DE1078581B DER22901A DER0022901A DE1078581B DE 1078581 B DE1078581 B DE 1078581B DE R22901 A DER22901 A DE R22901A DE R0022901 A DER0022901 A DE R0022901A DE 1078581 B DE1078581 B DE 1078581B
Authority
DE
Germany
Prior art keywords
dioxolanyl
vanillic acid
aliphatic
acid amides
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DER22901A
Other languages
German (de)
Inventor
Dr Albrecht Heymons
Dr-Ing Helmut Croon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Honeywell Riedel de Haen AG
Original Assignee
Riedel de Haen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riedel de Haen AG filed Critical Riedel de Haen AG
Priority to DER22901A priority Critical patent/DE1078581B/en
Publication of DE1078581B publication Critical patent/DE1078581B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Verfahren zur Herstellung von 1,3-Dioxolanyl-(4)-methyläthern von o-Vanillinsäureamiden Die Methyläther von o-Vanillinsäuredimethylamid und o-Vanillinsäurediäthylamid sind bekannt. Diese Methyläther üben eine anregende Wirkung auf Kreislauf und Atmung aus. Process for the preparation of 1,3-dioxolanyl- (4) -methyl ethers of o-Vanillinsäureamiden The methyl ethers of o-Vanillinsäuredimethylamid and o-Vanillinsäurediäthylamid are known. These methyl ethers have a stimulating effect on circulation and breathing the end.

Es wurde demgegenüber gefunden, daß 1,3-Dioxolanyl-(4)-methyläther von o-Vanillinsäureamiden der allgemeinen Formel in der R1 ein Wasserstoff- oder Halogenatom oder eine Nitrogruppe, R2 und R3 Wasserstoffatome, Alkyl-, Oxyalkyl- oder Cycloalkylreste sowie R4 und R5 Wasserstoffatome, Alkyl- oder Arylreste bedeuten, überraschenderweise eine ausgeprägte narkotische und sedative Wirkung besitzen.In contrast, it has been found that 1,3-dioxolanyl- (4) -methyl ethers of o-vanillic acid amides of the general formula in which R1 is a hydrogen or halogen atom or a nitro group, R2 and R3 are hydrogen atoms, alkyl, oxyalkyl or cycloalkyl radicals and R4 and R5 are hydrogen atoms, alkyl or aryl radicals, surprisingly have a pronounced narcotic and sedative effect.

Erfindungsgemäß werden die genannten 1,3-Dioxolanyl-(4)-methyläther von o-Vanillinsäureamiden erhalten, wenn man o-Vanillinsäureamide der allgemeinen Formel in der R1, R2 undR3 die angegebene Bedeutung haben, mit Glycerinmonochlorhydrin in an sich bekannter Weise, z. B. in Gegenwart von Natriumäthylat, umsetzt und die erhaltenen Glycerinäther in an sich bekannter Weise mit aliphatischen, aromatischen oder aliphatisch-aromatischen Aldehyden oder Ketonen zur Reaktion bringt.According to the invention, said 1,3-dioxolanyl- (4) -methyl ethers are obtained from o-vanillic acid amides if o-vanillic acid amides of the general formula in which R1, R2 andR3 have the meaning given, with glycerol monochlorohydrin in a manner known per se, e.g. B. in the presence of sodium ethylate, and the glycerol ether obtained reacts in a manner known per se with aliphatic, aromatic or aliphatic-aromatic aldehydes or ketones.

Die Ringschlußreaktion zu den 1,3-Dioxolanverbindungen wird in an sich bekannter Weise durch Zusatz saurer Katalysatoren, wie Salz.säure oder Toluolsulfonsäure, gefördert. Man kann auch in Gegenwart eines höher siedenden Lösungsmittels arbeiten und das bei der Verätherung entstehende Wasser durch azeotrope Destillation entfernen. The ring closure reaction to the 1,3-dioxolane compounds is in on known way by adding acidic catalysts, such as hydrochloric acid or toluenesulfonic acid, promoted. You can also work in the presence of a higher-boiling solvent and remove the water resulting from the etherification by azeotropic distillation.

Beispiel o-Vanillinsäureamid, Glycerinmonochlorhydrin und Natriumäthylat werden in molaren Mengen in Äthanol umgesetzt. Vom ausgefallenen Natriumchlorid wird abfiltriert und das Filtrat auf ein Viertel seines Volumens eingedampft. Den nach dem Erkalten abgesaugten Glycerinäther kristallisiert man aus Chloroform um. Example o-vanillic acid amide, glycerol monochlorohydrin and sodium ethylate are reacted in molar amounts in ethanol. From the precipitated sodium chloride is filtered off and the filtrate is evaporated to a quarter of its volume. The After cooling off, the glycerol ether sucked off is recrystallized from chloroform.

Ausbeute 45 °/o der Theorie. F. 99 bis 1000 C; sehr leicht löslich in Wasser.Yield 45% of theory. M.p. 99 to 1000 C; very easily soluble in water.

16,5 g des o-Vanillinsäureamid-1-glycerinäthers werden in 135 ccm Aceton, das 1 °/o Chlorwasserstoff enthält, gelöst und in Gegenwart von 10log wasserfreiem Natriumsulfat 14 Stunden bei Zimmertemperatur gerührt. Das Reaktionsgut wird dann durch Einleiten von Ammoniak auf Pn 7 eingestellt. Ausfallende anorganische Salze werden abgesaugt, dann wird die Lösung mit Kohle behandelt und das Lösungsmittel verdampft. Der Rückstand wird aus wäßrigem Methanol umkristallisiert. Der Äther aus 2-Dimethyl-4-oxymethyl-1,3-dioxolan und o-Vanillinsäureamid fällt in einer Ausbeute von 1 1?9 g, entsprechend 60°/o der Theorie, in farblosen Kristallen an und schmilzt bei 85 bis 860 C. 16.5 g of the o-vanillic acid amide-1-glycerol ether are in 135 ccm Acetone, which contains 1% of hydrogen chloride, dissolved and in the presence of 10log of anhydrous Sodium sulfate stirred for 14 hours at room temperature. The reaction mixture is then adjusted to Pn 7 by introducing ammonia. Failing inorganic salts are suctioned off, then the solution is treated with charcoal and the solvent evaporates. The residue is recrystallized from aqueous methanol. The ether from 2-dimethyl-4-oxymethyl-1,3-dioxolane and o-vanillic acid amide precipitates in one yield of 1 1? 9 g, corresponding to 60% of theory, in colorless crystals and melts at 85 to 860 C.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von 1,3-Dioxolanyl-(4)-methyläthern von o-Vanillinsäureamiden der allgemeinen Formel in der Rl ein Wasserstoff- oder Halogenatom oder eine Nitrogruppe, R2 und Rs Wassertoffatome, Alkyl-, Oxyalkyl- oder Cycloalkylreste sowie R4 und R5 Wasserstoffatome, Alkyl- oder Arylreste bedeuten, dadurch gekennzeichnet, daß man o-Vanillinsäureamide der allgemeinen Formel in der R1, R2 und R¢ die angegebene Bedeutung haben, mit Glycerinmonochlorhydrin in an sich bekannter Weise umsetzt und die erhaltenen Glycerinäther in an sich bekannter Weise mit aliphatischen, aromatischenoderaliphatisch-aromatischen Aldehyden oder Ketonen zur Reaktion bringt.PATENT CLAIM: Process for the preparation of 1,3-dioxolanyl- (4) -methyl ethers of o-vanillic acid amides of the general formula in which Rl is a hydrogen or halogen atom or a nitro group, R2 and Rs are hydrogen atoms, alkyl, oxyalkyl or cycloalkyl radicals and R4 and R5 are hydrogen atoms, alkyl or aryl radicals, characterized in that o-vanillic acid amides of the general formula in which R1, R2 and R [have the meaning given, is reacted with glycerol monochlorohydrin in a manner known per se and the glycerol ether obtained is reacted in a manner known per se with aliphatic, aromatic or aliphatic-aromatic aldehydes or ketones.
DER22901A 1958-03-15 1958-03-15 Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden Pending DE1078581B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DER22901A DE1078581B (en) 1958-03-15 1958-03-15 Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DER22901A DE1078581B (en) 1958-03-15 1958-03-15 Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden

Publications (1)

Publication Number Publication Date
DE1078581B true DE1078581B (en) 1960-03-31

Family

ID=7401250

Family Applications (1)

Application Number Title Priority Date Filing Date
DER22901A Pending DE1078581B (en) 1958-03-15 1958-03-15 Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden

Country Status (1)

Country Link
DE (1) DE1078581B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566773A1 (en) * 1984-06-28 1986-01-03 Bristol Myers Co NOVEL SUBSTITUTED BENZAMIDES, PROCESSES FOR PREPARING THESE COMPOUNDS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566773A1 (en) * 1984-06-28 1986-01-03 Bristol Myers Co NOVEL SUBSTITUTED BENZAMIDES, PROCESSES FOR PREPARING THESE COMPOUNDS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides

Similar Documents

Publication Publication Date Title
DE1445186C3 (en) 3,3'-di-2-imidazolin-2-yl-carbanilide
DE1014551B (en) Process for the preparation of substituted 4-oxycoumarins
DD140041B1 (en) METHOD FOR THE PRODUCTION OF LONG-CHAINED N-ALKYLDIMETHYLMORPHOLINES
DE1078581B (en) Process for the production of 1, 3-Dioxolanyl- (4) -methylaethern of o-Vanillinsaeuramiden
DE2166270C3 (en) Nicotinoylaminoethanesulfonyl-2amino-thiazole
DE940827C (en) Process for the production of organic arsenic compounds
AT229873B (en) Process for the preparation of 1,4-disubstituted piperazine derivatives
DE870857C (en) Process for the preparation of monohalogenated 1,3-dioxanes
DE740879C (en) Process for the preparation of higher amines of the morpholine series
DE942149C (en) Process for the preparation of substituted glycine amides
DE1618310C3 (en)
DE1470264C3 (en) Process for the preparation of 1-phenyl-1 - square brackets on thienyl- (2) square brackets to -carbinols
AT134629B (en) Process for the preparation of amino alcohols.
DE1154120B (en) Process for the production of new ajmaline derivatives
DE825409C (en) Process for the preparation of quinolinium compounds
DE1695363C3 (en) 1H-3.4 dihydro-2,3 benzoxazine and its substituted derivatives and processes for the preparation of these compounds
AT244344B (en) Process for the preparation of new pyrimidine compounds
AT251585B (en) Process for the preparation of new 6,7-dihydro-5H-pyrrolo- [3,4-d] -pyrimidines
AT275493B (en) Process for the preparation of N-substituted 1-aminoadamantanes and their salts
DE520078C (en) Process for the preparation of double compounds of quaternary salts of 3, 6-diamino-10-alkylacridinium
DE933754C (en) Process for the preparation of derivatives of tetrahydro-ª † -carboline
DE1088972B (en) Process for the preparation of ª †, ª †, ª † -Triphenylpropylaminen
CH416594A (en) Process for the production of a pharmaceutical with a muscle-relaxing effect
AT251570B (en) Process for the preparation of new 5-nitropyrrole derivatives
AT273967B (en) Process for the preparation of new salts of substituted s-triazines